Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease

被引:16
|
作者
Cai, Changzhou [1 ]
Song, Xin [1 ]
Yu, Chaohui [1 ]
机构
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
基金
中国国家自然科学基金;
关键词
Expression; bioinformatics; hepatocellular carcinoma; non-alcoholic fatty liver disease; CEP192; STEATOHEPATITIS; EPIDEMIOLOGY; BIOMARKERS; MICRORNAS; PATHWAY; CYCLE;
D O I
10.3233/CBM-190169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BACKGROUND: Hepatocellular carcinoma (HCC) is the leading cause of mortality worldwide. In recent years, the incidence of HCC induced by NAFLD is growing rapidly. OBJECTIVE: To screen for new pathogenic genes and related pathways both in NAFLD and HCC, and to explore the pathogenesis of progression from NAFLD to HCC. METHODS: Gene expression microarrays (GSE74656, GSE62232) were used for identifying differentially expressed genes (DEGs). Functional enrichment and pathway enrichment analyses indicated that these DEGs were related to cell cycle and extracellular exosome, which were closely related to NAFLD and HCC development. We then used the Search Tool for the Retrieval of Interacting Genes (STRING) to establish the protein-protein interaction (PPI) network and visualized them in Cytoscape. And the overall survival (OS) analysis and gene expression validation in TCGA of hub genes was performed. RESULTS: Seven hub genes, including CDK1, HSP90AA1, MAD2L1, PRKCD, ITGB3BP, CEP192, and RHOB were identified. Finally, we verified the expression level of ITGB3BP and CEP192 by quantitative real-time PCR in vitro. CONCLUSIONS: The present study implied possible DEGs, especially the new gene CEP192, in the progression of NAFLD developing to HCC. Further rigorous experiments are required to verify the above results.
引用
收藏
页码:69 / 78
页数:10
相关论文
共 50 条
  • [1] Hepatocellular carcinoma and non-alcoholic fatty liver disease
    Golabi, Pegah
    Rhea, Logan
    Henry, Linda
    Younossi, Zobair M.
    HEPATOLOGY INTERNATIONAL, 2019, 13 (06) : 688 - 694
  • [2] Hepatocellular carcinoma and non-alcoholic fatty liver disease
    Pegah Golabi
    Logan Rhea
    Linda Henry
    Zobair M. Younossi
    Hepatology International, 2019, 13 : 688 - 694
  • [3] A review on fatty liver disease or non-alcoholic fatty liver disease and hepatocellular carcinoma
    Toman, Daniel
    Vavra, Petr
    Jelinek, Petr
    Ostruszka, Petr
    Ihnat, Peter
    Foltys, Ales
    Roman, Jan
    RESEARCH JOURNAL OF BIOTECHNOLOGY, 2021, 16 (10): : 156 - 162
  • [4] Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
    Wong, Carrie R.
    Nguyen, Mindie H.
    Lim, Joseph K.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (37) : 8294 - 8303
  • [5] Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma
    Younossi, Zobair M.
    Henry, Linda
    JHEP REPORTS, 2021, 3 (04)
  • [6] Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
    Carrie R Wong
    Mindie H Nguyen
    Joseph K Lim
    World Journal of Gastroenterology, 2016, 22 (37) : 8294 - 8303
  • [7] Screening of co-pathogenic genes of non-alcoholic fatty liver disease and hepatocellular carcinoma
    Chen, Ting
    Zhang, Siwen
    Zhou, Dongmei
    Lu, Peipei
    Mo, Xianglai
    Tamrakar, Rashi
    Yang, Xi
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [8] Pathogenesis of hepatocellular carcinoma development in non-alcoholic fatty liver disease
    Shetty K.
    Chen J.
    Shin J.-H.
    Jogunoori W.
    Mishra L.
    Current Hepatology Reports, 2015, 14 (2) : 119 - 127
  • [9] Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
    El Dahan, Karim Seif
    Daher, Darine
    Singal, Amit G.
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 : S207 - S219
  • [10] Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease
    Valenti, Luca
    Pedica, Federica
    Colombo, Massimo
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (02) : 154 - 163